AAAAAA

   
Results: 1-10 |
Results: 10
Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?
Authors: Sibley, CH Hyde, JE Sims, PFG Plowe, CV Kublin, JG Mberu, EK Cowman, AF Winstanley, PA Watkins, WM Nzila, AM
Citation: Ch. Sibley et al., Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?, TRENDS PARA, 17(12), 2001, pp. 582-588
New agents to combat malaria
Authors: Beeson, JG Winstanley, PA McFadden, GI Brown, GV
Citation: Jg. Beeson et al., New agents to combat malaria, NAT MED, 7(2), 2001, pp. 149-150
Chemotherapy for falciparum malaria: The armoury, the problems and the prospects
Authors: Winstanley, PA
Citation: Pa. Winstanley, Chemotherapy for falciparum malaria: The armoury, the problems and the prospects, PARASIT TOD, 16(4), 2000, pp. 146-153
Factors affecting the UV emission from pulsed surface discharges
Authors: Tuema, FA MacGregor, SJ Fouracre, RA Fulker, DJ Finlayson, AJ Winstanley, PA
Citation: Fa. Tuema et al., Factors affecting the UV emission from pulsed surface discharges, IEEE PLAS S, 28(5), 2000, pp. 1588-1592
Biliary metabolites of beta-artemether in rats: Biotransformations of an antimalarial endoperoxide
Authors: Maggs, JL Bishop, LPD Edwards, G O'Neill, PM Ward, SA Winstanley, PA Park, BK
Citation: Jl. Maggs et al., Biliary metabolites of beta-artemether in rats: Biotransformations of an antimalarial endoperoxide, DRUG META D, 28(2), 2000, pp. 209-217
Disposition of intravenous pyrimethamine in healthy volunteers
Authors: Almond, DS Szwandt, ISF Edwards, G Lee, MG Winstanley, PA
Citation: Ds. Almond et al., Disposition of intravenous pyrimethamine in healthy volunteers, ANTIM AG CH, 44(6), 2000, pp. 1691-1693
Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: Genotyping of dihydrofolate reductase anddihydropteroate synthase of Kenyan parasites
Authors: Nzila, AM Mberu, EK Sulo, J Dayo, H Winstanley, PA Sibley, CH Watkins, WM
Citation: Am. Nzila et al., Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: Genotyping of dihydrofolate reductase anddihydropteroate synthase of Kenyan parasites, ANTIM AG CH, 44(4), 2000, pp. 991-996
Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethaminel/sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum
Authors: Nzila, AM Nduati, E Mberu, EK Sibley, CH Monks, SA Winstanley, PA Watkins, WM
Citation: Am. Nzila et al., Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethaminel/sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum, J INFEC DIS, 181(6), 2000, pp. 2023-2028
More on 'the efficacy of antifolate antimalarial combinations in Africa'
Authors: Watkins, WM Mberu, EK Winstanley, PA Plowe, CV
Citation: Wm. Watkins et al., More on 'the efficacy of antifolate antimalarial combinations in Africa', PARASIT TOD, 15(4), 1999, pp. 131-132
The antimalarial triazine WR99210 and the prodrug PS-15: Folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate modeof action of the prodrug
Authors: Kinyanjui, SM Mberu, EK Winstanley, PA Jacobus, DP Watkins, WM
Citation: Sm. Kinyanjui et al., The antimalarial triazine WR99210 and the prodrug PS-15: Folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate modeof action of the prodrug, AM J TROP M, 60(6), 1999, pp. 943-947
Risultati: 1-10 |